The promise of quantum computing often evokes images of futuristic technology, complex algorithms, and perhaps, for many, a sense of impenetrable mystery. But a new initiative at the University of Chicago isn’t focused on explaining the intricacies of quantum mechanics to the public; it’s focused on quietly applying them to medicine, with the understanding that the most impactful advances will happen behind the scenes, improving patient outcomes without requiring patients to understand the underlying physics. This isn’t about quantum theory becoming bedside manner, but about leveraging its power to fundamentally reshape diagnostics and treatment.
Greg Engel, a professor at the University of Chicago Pritzker School of Molecular Engineering and Chemistry Department, frames the ambition with a familiar analogy: “Think of an MRI machine. You may not know that it’s flipping nuclear spins in water and imaging the water in your body, but you know when it catches a tumor early enough that it can be treated.” The $21 million Berggren Center for Quantum Biology and Medicine, established last year thanks to a donation from philanthropist Thea Berggren, aims to replicate this success – delivering powerful, effective healthcare solutions built on quantum innovation, but presented as seamless improvements to existing care. This approach is a deliberate counterpoint to the often-sensationalized portrayal of quantum science.
This piece references the news.uchicago.edu report.
The core challenge, as articulated by Julian Solway, professor emeritus of medicine at UChicago and co-director of the center alongside Engel, isn’t just developing the technology, but bridging the vast intellectual gap between quantum physicists and medical professionals. “One of the Berggren Center’s fundamental goals is training a medical workforce to be able to leverage quantum physics,” Solway explains. The center’s strategy isn’t to force doctors to become quantum physicists, but to cultivate a new generation of “bilingual scientists” – individuals fluent in both the language of the body and the language of quantum mechanics. This is achieved through integrated MD/PhD programs and specialized training for MD students, fostering collaboration between clinicians and quantum scientists.
This emphasis on translation is crucial. Engel clarifies that quantum science, in this context, isn’t about philosophical debates or science fiction, but about a precise mathematical model for understanding the behavior of particles at the smallest scales. It’s a tool for prediction, and increasingly, a tool with a proven track record. The center’s focus is on applying these established principles to biological systems, seeking to understand and ultimately manipulate processes within the human body. Solway emphasizes that medicine is, at its heart, problem-solving, and quantum technologies represent a potentially powerful addition to the medical “arsenal.”
One specific area of focus for the center is detecting tissue hypoxia – a condition where tissues aren’t receiving enough oxygen. Solway highlights its relevance to a wide range of diseases, from cardiovascular problems to cancer. Current methods for assessing tissue oxygenation are often invasive or provide limited information. Quantum sensing technologies, however, offer the potential for non-invasive, whole-body visualization of oxygen levels, providing critical insights for clinicians in critical care and cardiology. Engel expands on this, explaining that quantum sensing will allow researchers to observe cellular processes with unprecedented detail, revealing how cells communicate and function as a collective. This deeper understanding could unlock new avenues for diagnosing and treating disease.
However, it’s important to acknowledge the limitations. The Berggren Center is, by design, a long-term investment. While the potential of quantum sensing and computing in medicine is significant, these technologies are still in their early stages of development. The leap from laboratory proof-of-concept to clinically viable devices is substantial, requiring significant engineering challenges to be overcome. Furthermore, the cost of these technologies is likely to be high initially, potentially creating disparities in access to care. The center’s focus on training is also a long-term strategy; it will take years to build a sufficient workforce of “bilingual scientists” capable of driving innovation in this field.
The next crucial steps involve not just refining the technology, but demonstrating its clinical utility. Researchers will need to conduct rigorous clinical trials to validate the accuracy and effectiveness of quantum-based diagnostics and therapeutics. A key question will be whether these technologies can provide information that is not available through existing methods, and whether that information translates into improved patient outcomes. Specifically, will quantum sensing of tissue hypoxia lead to earlier diagnoses, more targeted treatments, and ultimately, better survival rates for patients with relevant conditions? The success of the Berggren Center, and the future of quantum medicine, hinges on answering that question.
